Cambridge Heart issues $962,000 warrant call

May 6, 2010 by MassDevice staff

Cambridge Heart Inc. issues a warrant call for $962,000 worth of warrants it issued last year as part of a Series D financing round.

CAMH logo

Cambridge Heart Inc. (OTC:CAMH) issued a call for nearly $1 million worth of long-term warrants it issued last year as part of a Series D funding round.

The Tewksbury, Mass.-based heart test maker said it would net $754,000 if all holders of the warrants for 6,775,611 shares exercise them at their 14.2 cent share price. Cambridge Heart already pulled in $208,000 from the exercise of some of the warrants.

The call was triggered after the company's stock closed higher than 28.4 cents for 20 consecutive trading days. CAMH stock was at 38 cents in mid-morning trading May 6. Cambridge Heart said it will re-purchase any unexercised warrants after 6:30 p.m. June 4.

The Series D round also included short-term warrants for about 11.3 million shares, at 10.7 cents per share. If all of those warrants were exercised the company would land another $1.2 million, but the company is not calling those warrants yet. To date their exercise resulted in about $261,000 from a pair of investors in the Series D round, according to a press release.

The cash will come in handy for Cambridge Heart as it looks to find more customers for an OEM version of its microvolt T-wave alternans cardiac monitor. The Food & Drug Administration granted 510(k) clearance to the OEM module in April, clearing the way for a deal with Cardiac Science Corp. (NSDQ:CSCX) to incorporate the module into its heart stress-testing equipment.